Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bilateral Prophylactic Mastectomy; Should we Preserve the Pectoral Fascia?: Protocol of a Dutch Double Blinded, Prospective, Randomized Controlled Pilot Study With a Within-subject Design

NCT05391763 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT05391763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05391763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bilateral Prophylactic Mastectomy; Should we Preserve the Pectoral Fascia?: Protocol of a Dutch Double Blinded, Prospective, Randomized Controlled Pilot Study With a Within-subject Design
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2022
Completion date
December 1, 2023
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bilateral prophylactic mastectomy, brca1/2 mutation, pectoral fascia, seroma